Representative before the EPO

Company dna saunders and dolleymore llp
no operation time available
2 offices
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 5 EP applications Jennifer Ann Vaughan has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after March 23, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13742365

SINGLE DOSE ORAL FORMULATIONS AND METHODS FOR TREATMENT OF CATS WITH ECTOPARASITICIDAL SPINOSAD

IPC classification:
A61K 9/20, A61K 9/00, A01N 43/22
Applicant:
Eli Lilly and Company Limited
Agent:
Jennifer Ann Vaughan, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP13773518

METHODS FOR IMPROVING CHICKEN PRODUCTION

IPC classification:
A23K 1/18, A23K 1/16, C07D 401/04
Applicant:
Eli Lilly and Company Limited
Agent:
Jennifer Ann Vaughan, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED
EP13785745

AGGRECANASE INHIBITORS

IPC classification:
A61K 31/4166, C07D 233/76
Applicant:
Eli Lilly and Company Limited
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
The patent has been granted
EP15160519

PARASITICIDAL DIHYDROISOXAZOLE COMPOUNDS

IPC classification:
A01N 43/90, A01N 43/80, C07D 495/04, C07D 417/04, C07D 413/14, C07D 413/04
Agent:
Jennifer Ann Vaughan, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815185

ECTOPARASITICIDAL METHODS AND FORMULATIONS

IPC classification:
A61K 47/22, A61K 47/10, A61K 31/704, A61K 9/00, A01N 43/22, A61P 33/14
Applicant:
Eli Lilly and Company Limited
Agent:
Jennifer Ann Vaughan, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature